Evecxia Therapeutics
PrivateLast Round
VC Round
Sep 22, 2025
Total Funding Raised
$6.5M
Company Overview
Evecxia Therapeutics is a biotechnology company that develops proprietary drug delivery technologies to amplify serotonin synthesis for the treatment of neuropsychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evecxia Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Evecxia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 22, 2025 | ||||
| VC Round | Aug 27, 2021 | ||||
| Series A | Jun 30, 2020 |
Key People
Founding team and executive leadership
Evecxia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Collage Venture Partners | VC Round |
| Transhuman Capital | Series A |
Evecxia Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evecxia Therapeutics's valuation, stock price, and market status.